EARLY Labs
Multi-cancer Screening Platform
StartupEARLY Labs is a Netanya-based startup in the Health Tech & Life Sciences sector, established in 2020. Multi-cancer Screening Platform. The company has raised a total of $4M across 1 funding round, currently at the Seed stage. EARLY Labs was founded by Michal Mark Danieli. Key investors include Undisclosed Investor(s). The company has 1-10 employees. Core technologies: Artificial Intelligence, Machine Learning, Biologicals, Molecules, Sensing, Scent.
With $4M in total funding, EARLY Labs is a Seed-stage company operating in Health Tech & Life Sciences. The company follows a B2B2C business model. Product stage: Clinical Trial. The company holds 1 patent.
- StageSeed
- ProductClinical Trial
- ModelB2B2C
- Employees1-10
- HQNetanya
- Last Round$4M
- Undisclosed Investor(s)
Michal Mark DanieliFounder & CEO
4 articles covered by sources including www.dailymail.co.uk,
www.jewishnews.co.uk,
www.timesofisrael.com,
www.mako.co.il.
What does EARLY Labs do?
EARLY Labs is a Bio-Tech company, operating in the field of Volatile Organic Compound based diagnostics. The company is developing a revolutionary multi-cancer test platform, currently focusing on lung cancer, detecting lung cancer in urine samples, from it's earliest stages – with groundbreaking 90% stage I sensitivity and specificity results. By Q4 2024 the platform will be calibrated to run Colon testing as well, and other cancer types to follow. Simplicity of the test, which can be done at home or at pharmacies, using a urine collection kit, is expected to break existing uptake barriers such as invasiveness, radiation, long waiting lists, inconvenience and more, and completely change the cancer screening paradigm.
How much funding has EARLY Labs raised?
EARLY Labs has raised $4M in total funding across 1 rounds. The company is currently at the Seed stage. Key investors include Undisclosed Investor(s).
Who founded EARLY Labs?
EARLY Labs was founded in 2020 by Michal Mark Danieli (Founder & CEO).
What sector is EARLY Labs in?
EARLY Labs operates in Health Tech & Life Sciences, Pharma & Medical Biotechnology, Test Diagnostics & Screening, with core technologies in Artificial Intelligence, Machine Learning, Biologicals, Molecules, Sensing, Scent. Target customers: Healthcare & Life Sciences, Healthcare, Providers, Patients.
Where is EARLY Labs located?
EARLY Labs is based in Meir Ariel St 4, Netanya, Israel.